One of the key components of Wilson Sonsini Goodrich & Rosati’s life sciences practice is its longtime representation of biotechnology companies, innovative biotech entrepreneurs, and progressive biotech investors. The firm’s work in the biotech community dates back to the formative years of the industry, when bold new companies first began to develop and commercialize scientific discoveries.
Today, the firm’s biotechnology practice consists of more than 140 professionals, including attorneys, patent agents, and scientific advisors. A substantial number of our practitioners have advanced degrees in biology, chemistry, engineering, or other scientific fields. Similarly, a large number of our professionals have experience working in laboratory, medical, or research facilities. The team also includes attorneys who have served as in-house legal counsel for major life sciences companies.
WSGR has consistently represented biotech companies at all stages, from formation to exit. Our work with emerging biotech companies is typically focused on two areas that are vital to early-stage enterprises: intellectual property and finance.